Sugar acids and derivatives
Medchemexpress LLC Acyl-CoA oxidase | 61116-22-1 | 100 U
Acyl-CoA oxidase (ACO) is a peroxisomal catalyst and a key rate-limiting enzyme in the process of peroxisomal fatty acid β-oxidation. It participates in lipid catabolism and phytohormone biosynthesis pathways.
- Peroxisomal catalyst
- Key rate-limiting enzyme in peroxisomal fatty acid β-oxidation
- Participates in lipid catabolism and phytohormone biosynthesis pathways
- Appearance: solid, light yellow to yellow
Medchemexpress LLC D-α-hydroxyglutaric acid disodium | 103404-90-6 | 98.0% | 192.08 | C5H6Na2O5 | 10 MG
D-α-hydroxyglutaric acid disodium is the disodium salt of the R-enantiomer of 2-hydroxyglutaric acid, supplied as a solid research reagent and biochemical standard for studies of D-2-hydroxyglutaric acid metabolism and α-ketoglutarate-dependent enzyme activity. Typical properties: C5H6Na2O5, Mw 192.08, CAS 103404-90-6.
- High purity suitable for research applications (>98%).
- Disodium salt form for improved aqueous solubility.
- Useful as a biochemical standard in metabolic and enzyme studies.
- Reported to modulate ATP synthase activity and increase ROS in biochemical assays.
- Stable when stored sealed away from moisture; in solvent: -80°C (6 months), -20°C (1 month).
![Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 25mg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000097080.png-250.jpg)
Apexbio Technology LLC heparin cofactor II precursor fragment [Homo sapiens] 25mg
Heparin cofactor II precursor fragment is a thrombin inhibitor peptide targeting human thrombin (factor IIa) It is designed to inhibit thrombin activity thereby modulating blood coagulation pathways Heparin cofactor II precursor fragment exerts its biological activity primarily through serine protease inhibition facilitated in the presence of heparin or dermatan sulfate Based on these pharmacological properties heparin cofactor II precursor fragment holds research potential in investigating thrombin inhibition mechanisms blood coagulation pathways and conditions associated with altered coagulation such as heparin cofactor II deficiency and hypercoagulability disorders
Aobchem 1-(3-Bromo-5-methoxyphenyl)cyclobutanol | 97% | CAS 2901084-83-9 | C11H13BrO2 | 5g
1-(3-Bromo-5-methoxyphenyl)cyclobutanol | 97% | CAS 2901084-83-9 | C11H13BrO2 | 5g
Aobchem (3-Chloro-4-methoxyphenyl)(cyclohexyl)methanone | 95% | CAS 1094648-36-8 | C14H17ClO2 | 250mg
(3-Chloro-4-methoxyphenyl)(cyclohexyl)methanone | 95% | CAS 1094648-36-8 | C14H17ClO2 | 250mg
Medchemexpress LLC Bet-bay 002 | 1588521-78-1 | 99.8% | 403.86 g/mol | C22H18ClN5O | 100MG
BET-BAY 002 is a small-molecule BET bromodomain inhibitor intended for research use. It demonstrates activity in multiple myeloma models and is provided as a high-purity solid for in vitro and preclinical studies. The compound is soluble in DMSO and is offered in multiple pack sizes to support assay development and screening.
- Potent BET bromodomain inhibitor with reported efficacy in multiple myeloma models.
- High purity (99.8%) suitable for biological assays.
- Soluble in DMSO for convenient reconstitution.
- Available in multiple quantities including a 100 mg package.
- Molecular weight 403.86 g/mol and formula C22H18ClN5O.
TARGETMOL CHEMICALS INC 4-Methylumbelliferyl-beta-D-xy
Also available in 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. 4-Methylumbelliferyl-beta-D-xylopyranoside (4-Methylumbelliferyl-beta-D-xyloside) exhibits bursting steady-state kinetics in biological experiments, which supports the conclusion of rapid hydrolysis of the glycosidic bond of the substrate 4-Methylumbelliferyl-beta-D-xylopyranoside 4-Methylumbelliferyl-beta-D-xylopyranoside can be used for beta- xylosidase activity studies. Purity 99.46%
![eMolecules 21085-72-3 | Acetobromo-alpha-D-glucuronic acid methyl ester | Combi-Blocks | MFCD00061613 | 397.174 | C13H17BrO9 | 97.000 | COC(=O)[C@H]1O[C@H](Br)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O | 1g | 117564446](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000472755.jpg-250.jpg)
eMolecules 21085-72-3 | Acetobromo-alpha-D-glucuronic acid methyl ester | Combi-Blocks | MFCD00061613 | 397.174 | C13H17BrO9 | 97.000 | COC(=O)[C@H]1O[C@H](Br)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O | 1g | 117564446
Acetobromo-alpha-D-glucuronic acid methyl ester | Combi-Blocks | 21085-72-3 | MFCD00061613 | 397.174 | C13H17BrO9 | 97.000 | COC(=O)[C@H]1O[C@H](Br)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O | 1g | 117564446
